The Safety and Efficacy of the Suture-Mediated Closure System

Inclusion Criteria: * Between 18 years old and 85 years old, randomized * Patients who can be examined or treated with a common femoral artery puncture interventional catheter using a 5F to 22F sheath tube * Patient(or their guardians) who submitted a written informed consent for the this trial Exclusion Criteria: * Known to be pregnant or lactating * The diameter of femoral artery on the puncture side was less than 5mm * Patients requiring anterograde puncture approach * Have participated in or plan to participate in another clinical trial in the same period * Known allergy to any components of the device, and/or contraindications to contrast agents and anticoagulants * International normalized ratio (INR) \>2.0 * Traumatic vascular injury at the approach site * Systemic or local groin infection * Cerebrovascular accident or myocardial infarction within 3 months * An arterial catheter needs to be placed at the access site * Morbidly obese (BMI ≥40 kg/m2) * The entire common femoral artery wall assessed by ultrasound, calcification located in the anterior wall cut, the extent of more than 50% circumferential or common femoral artery stenosis ≥50 * Femoral artery aneurysm, arteriovenous fistula or pseudoaneurysm in common femoral artery * Using a clip vessel occluder at the past ipsilateral femoral artery access site * Use of a puncture point occlusion device at the ipsilateral femoral access site within the past 30 days * Underwent an intervention via ipsilateral femoral artery puncture within the past 30 days or within the next 30 days * Ipsilateral femoral vein sheath needed to be used * Evidence of previous common femoral artery surgery on the same side (e.g., inguinal incision) * Hematoma at ipsilateral arterial access * Other circumstances that the investigator deemed inappropriate for participation in the trial.femoral artery aneurysm, arteriovenous fistula or pseudoaneurysm in common femoral artery